Michael Andriole

Currently holds positions in Chimerix Inc and Endocyte Inc

Position	Company	Period
Chief Business Officer	Chimerix Inc	April 4, 2019 -
Chief Financial Officer	Endocyte Inc	Feb. 20, 2017 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-02-14	2025-02-13	Chimerix Inc (CMRX)	PS Planned sale	7,370 -1.2% 4.52 USD 33,282	7,370 -1.2%	4.52	USD 33,282
2025-01-31	2025-01-30	Chimerix Inc (CMRX)	PS Planned sale	2,350 -0.4% 4.10 USD 9,636	2,350 -0.4%	4.10	USD 9,636
2024-08-09	2024-08-08	Chimerix Inc (CMRX)	PS Planned sale	1,285 -0.3% 0.83 USD 1,065	1,285 -0.3%	0.83	USD 1,065
2024-02-16	2024-02-14	Chimerix Inc (CMRX)	PS Planned sale	1,744 -0.4% 1.04 USD 1,809	1,744 -0.4%	1.04	USD 1,809
2023-05-19	2023-05-18	Chimerix Inc (CMRX)	PP Planned purchase	51,700 +16.9% 1.14 USD 59,150	51,700 +16.9%	1.14	USD 59,150
2022-05-18	2022-05-17	Chimerix Inc (CMRX)	PP Planned purchase	15,000 +7.6% 1.71 USD 25,635	15,000 +7.6%	1.71	USD 25,635
2020-03-17	2020-03-16	Chimerix Inc (CMRX)	PP Planned purchase	33,300 +28.6% 1.43 USD 47,522	33,300 +28.6%	1.43	USD 47,522
2019-11-07	2019-11-06	Chimerix Inc (CMRX)	B Purchase	100,000 +inf% 1.56 USD 156,000	100,000 +inf%	1.56	USD 156,000